Statistics for genOway SA (id:10965 ALGEN)

Valuation metrics

Market cap

30.05M

Enterprise value

33.02M

Trailing P/E (ttm)

17.62

Forward P/E

24.67

PEG ratio

24.67

Price/Sales (ttm)

1.07

Price/Book (mrq)

2.02

Enterprise Value/Revenue

1.65

Enterprise Value/EBITDA

5.50

Overview

Shares outstanding

8.12M

Float

Shares short

% Held by insiders

0.19%

% Held by institutions

0.22%

Average volume (10 days)

6.84K

Average volume (90 days)

Price summary

52-Week low

3.24

52-Week high

4.91

52-Week change

-14.32%

Beta

0.55

50-Day moving average

3.68

200-Day moving average

3.97

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

December 31th, 2023

Profitability

Profit margin

4.47%

Operating margin

3.67%

Operational effectiveness

Return on assets

2.45%

Return on equity

7.20%

Income statement

Revenue (ttm)

Revenue per share (ttm)

Quarterly revenue growth (yoy)

-0.31

Gross profit (ttm)

18.80M

EBITDA

6.01M

Net income to common (ttm)

1.26M

Diluted EPS (ttm)

0.21

Quarterly earnings growth (yoy)

-30.60%

Balance sheet

Total cash (mrq)

4.86M

Total cash per share (mrq)

Total debt (mrq)

6.38M

Total Debt/Equity (mrq)

35.85

Current ratio (mrq)

198.80%

Book value per share (mrq)

1.83

Cash flow

Cash flow statement

592.19K

Levered free cash flow (LFCF)

1.57M